These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival. Kiviniemi A, Gardberg M, Frantzén J, Parkkola R, Vuorinen V, Pesola M, Minn H. J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547 [Abstract] [Full Text] [Related]
3. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J. J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [Abstract] [Full Text] [Related]
4. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas. Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, DeAngelis LM, Holland EC, Hormigo A. Neuro Oncol; 2011 Nov; 13(11):1244-51. PubMed ID: 21831900 [Abstract] [Full Text] [Related]
5. Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas. Husain H, Savage W, Grossman SA, Ye X, Burger PC, Everett A, Bettegowda C, Diaz LA, Blair C, Romans KE, Holdhoff M. J Neurooncol; 2012 Aug; 109(1):123-7. PubMed ID: 22492246 [Abstract] [Full Text] [Related]
6. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas. Dahlrot RH. Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629 [Abstract] [Full Text] [Related]
7. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. Lin Y, Jiang T, Zhou K, Xu L, Chen B, Li G, Qiu X, Jiang T, Zhang W, Song SW. Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435 [Abstract] [Full Text] [Related]
8. The prognostic role of preoperative systemic immune-inflammation index and albumin/globulin ratio in patients with newly diagnosed high-grade glioma. Liang R, Li J, Tang X, Liu Y. Clin Neurol Neurosurg; 2019 Sep; 184():105397. PubMed ID: 31306893 [Abstract] [Full Text] [Related]
9. Serum lactate levels are associated with glioma malignancy grade. Branco M, Linhares P, Carvalho B, Santos P, Costa BM, Vaz R. Clin Neurol Neurosurg; 2019 Nov; 186():105546. PubMed ID: 31605893 [Abstract] [Full Text] [Related]
10. In vitro neurosphere formation correlates with poor survival in glioma. C Jayakrishnan P, H Venkat E, M Ramachandran G, K Kesavapisharady K, N Nair S, Bharathan B, Radhakrishnan N, Gopala S. IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962 [Abstract] [Full Text] [Related]
11. Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. Kemerdere R, Akgun MY, Toklu S, Aydin S, Orhan B, Inal BB, Korkmaz TS, Aktas B, Kacira T, Tanriverdi T. Turk Neurosurg; 2021 Feb; 31(3):399-403. PubMed ID: 33759165 [Abstract] [Full Text] [Related]
12. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review. Broekx S, Weyns F, De Vleeschouwer S. Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151 [Abstract] [Full Text] [Related]
13. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive. Ahmed KI, Govardhan HB, Roy M, Naveen T, Siddanna P, Sridhar P, Suma MN, Nelson N. Indian J Cancer; 2019 Aug; 56(1):65-69. PubMed ID: 30950448 [Abstract] [Full Text] [Related]
14. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653 [Abstract] [Full Text] [Related]
15. Serum microRNA is a biomarker for post-operative monitoring in glioma. Morokoff A, Jones J, Nguyen H, Ma C, Lasocki A, Gaillard F, Bennett I, Luwor R, Stylli S, Paradiso L, Koldej R, Paldor I, Molania R, Speed TP, Webb A, Infusini G, Li J, Malpas C, Kalincik T, Drummond K, Siegal T, Kaye AH. J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353 [Abstract] [Full Text] [Related]
16. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients. Chen P, Zhang G, Zhou Q, Li Z. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32639004 [Abstract] [Full Text] [Related]
17. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M. J Neurooncol; 2016 Mar 31; 127(1):53-61. PubMed ID: 26626490 [Abstract] [Full Text] [Related]
18. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. Santangelo A, Imbrucè P, Gardenghi B, Belli L, Agushi R, Tamanini A, Munari S, Bossi AM, Scambi I, Benati D, Mariotti R, Di Gennaro G, Sbarbati A, Eccher A, Ricciardi GK, Ciceri EM, Sala F, Pinna G, Lippi G, Cabrini G, Dechecchi MC. J Neurooncol; 2018 Jan 31; 136(1):51-62. PubMed ID: 29076001 [Abstract] [Full Text] [Related]
19. Expression and prognostic role of E2F transcription factors in high-grade glioma. Yu H, Li Z, Wang M. CNS Neurosci Ther; 2020 Jul 31; 26(7):741-753. PubMed ID: 32064771 [Abstract] [Full Text] [Related]
20. Glioma SOX2 expression decreased after adjuvant therapy. Yu W, Ren X, Hu C, Tan Y, Shui Y, Chen Z, Zhang L, Peng J, Wei Q. BMC Cancer; 2019 Nov 12; 19(1):1087. PubMed ID: 31718604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]